Jones Christopher Ian Montague
SEC CIK 1292762 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BDX | Becton Dickinson | Dir | 24.3K | — | — | 6 | 2022-01-25 | 2026-01-27 |
Most active insiders at BDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polen Thomas E Jr | COB, CEO, Pres, Dir | — | $1.17M |
| 2 | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | — | $784.2K |
| 3 | Goette Roland | EVP, Pres, EMEA | — | $440.9K |
| 4 | SCOTT BERTRAM L | Dir | — | $212.3K |
| 5 | Feld Michael | EVP, Pres, Life Sciences | — | $167.4K |
| 6 | Menziuso Peter | EVP, Pres, BDI | — | — |
| 7 | Roque Vitor | Interim CFO | — | — |
| 8 | Spikner Pamela L. | SVPController, Chief Acct Off | — | — |
| 9 | Shan David | EVP, Chief ISC Off | — | — |
| 10 | Waldstreicher Joanne | Dir | — | — |
| 22 | Jones Christopher Ian Montague | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-29 | 2026-01-27 | BDX | Becton Dickinson | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +1,098 | 24.3K | +5% | $0 | |
| 2025-01-30 | 2025-01-28 | BDX | Becton Dickinson | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +930 | 22.7K | +4% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | Becton Dickinson | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +900 | 21.4K | +4% | $0 | |
| A | 2023-12-13 | 2023-01-24 | BDX | Becton Dickinson | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +848 | 20.2K | +4% | $0 |
| 2023-01-26 | 2023-01-24 | BDX | Becton Dickinson | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +848 | 29.2K | +3% | $0 | |
| 2022-01-26 | 2022-01-25 | BDX | Becton Dickinson | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +820 | 18.7K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations